FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - LUNG





Form # 785-1-031

Clin Path DEFINITIONS
    Primary Tumor (T)

TX Primary tumor cannot be assessed, or tumor proven by presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy

T0 No evidence of primary tumor

Tis Carcinoma in situ:

T1 Tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e. not in main bronchus)

T2 Tumor with any of the following features of size or extent:

More than 3 cm in greatest dimension

Involves main bronchus, 2 cm or more distal to the carina Invades the visceral pleura

Associated with atelectasis or obstructive pneumonitis which extends to the hilar region but does not involve the entire lung

T3 Tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium; or tumor in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or associated atelectasis or obstructive pneumonitis of the entire lung

T4 Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or tumor with a malignant pleural effusion
    Lymph Node (N)

NX Regional lymph nodes cannot be assessed

N0 No regional lymph node metastasis

N1 Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including direct extension

N2 Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s)

N3 Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene or supraclavicular lymph node(s)
    Distant Metastasis (M)

MX Presence of distant metastasis cannot be assessed

M0 No distant metastasis

M1 Distant metastasis

Pathologic Stage by: M.D. Date:

Clinical Stage by: M.D. Date:

Clin  Path  Stage Grouping

Occult TX N0 M0

0 Tis N0 M0

I T1 N0 M0
      T2 N0 M0

II T1 N1 M0
      T2 N1 M0

IIIA T1 N2 M0
      T2 N2 M0
      T3 N0 M0
      T3 N1 M0
      T3 N2 M0

IIIB Any T N3 M0
      T4 Any N M0

IV Any T Any N M1

Stage Grouping by: M.D. Date:

THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

Comments:

Patient Name: